The Canadian COVID-19 Prospective Cohort Study

Summary

This study is a large, multi-centre, one to three year follow-up of COVID-19 patients who are hospitalized in critical care units (ICU)) and non-hospitalized patients (those who were tested positive and asked to isolate at home). The study will look at short-term outcomes for non-hospitalized patients and longer-term (1, 3, 6, and 12 month) outcomes in ICU patients and their caregivers. Following this time, participants will be invited to continue participation for an 18, 24, 30 and 36 month follow ups.
The study will assess clinical, sociodemographic, genetic, and immunological predictors of patient recovery, and find out whether clinical risk factors (e.g. age, baseline health, socio-demographic status, comorbid illness and some genetic / coagulation risk factors) are predictors of short- and long-term outcomes in patients with COVID-19.

Eligibility

Currently recruiting participants: Yes

Eligible gender: Male, Female, Transgender, Other

Eligible ages: 19 to 110

Accepts healthy participants: Yes

Inclusion criteria:

You are eligible for this study if:
1. You are older than 18 years of age
2. You have a positive COVID-19 test and are / were admitted to the ICU
3. You have a positive COVID-19 test and are isolating or recovering at home
4. You are a family caregiver for an ICU COVID-19 patient recovering at home, and over 18. You can be enrolled at the same time as your ICU patient.

Exclusion criteria:

You are not eligible to participate if you are:
1) Younger than 19 years of age
2) In a non-ICU hospital ward for treatment of COVID-19
3) Cannot read and speak English
4) Are receiving financial compensation for caregiving for a COVID-19 patient

Participate

Fill out the following form if you want to participate in this research

Method of contact

Collection of personal information
Your personal information is collected under the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If you have any questions about the collection or use of this information, please visit our Access to Information page.

Additional information

Contact information

Please contact mskimaging@ucalgary.ca for further information

Principal investigator:

Sarah Manske

Clinical trial:

No

REB-ID:

REB20-1780